The Pharmaceutical Journal, November 11, 2000

Back issues

Comment

An Onlooker's Notebook   704

• Breezes blow
• Surgery at sea
• Bats and belfries

Leading Articles   705

• A prescription for nutrition

News   706-708

• Croydon walk-in centre pharmacy funding withdrawn 706
• Use of dispensing nurses in pharmacies proposed 706
• EC to act against IMS 706
• European Court quashes Bayer fine 706
• Hospital pharmacists suffering burnout, guild president says 707
• New Welsh NHS director 707
• Pharmed wants hybrid ETP model 707
• EU to encourage paediatric medicines research 707
• Paediatric prescribing statement 707
• Dermatology role for pharmacists? 708
• Hospital pharmacy visit for MPs 708
• Three POM-to-P changes 708
• EC vitamin demand 708

Clinical Pharmacy   709-712

• Is phenylpropanolamine in UK products really unsafe? 709
• Advice to patients 709
• Lack of obesity management services found by survey 710
• Orlistat treatment in type 2 diabetes 710
• No evidence of hepatic toxicity with pioglitazone, says Takeda 710
• New antiepileptic with "no known interactions" launched 711
• New cancer test claims in doubt 711
• Pesticide link to Parkinson’s disease? 711
• NICE multiple sclerosis guidance delayed until next year 712
• Seizure rate for bupropion no greater than expected, says MCA 712
• Zanamivir prophylaxis prevents influenza transmission, study shows 712
• Rapid influenza test available soon 712
• New diabetes guide issued 712

Business   713

• Boots is a business in transition, says chairman 713
• Lloyds refurbishes heritage branch 713
• Pharmacy2u receives £3m investment 713
• Briefly 713

The Society   714

• Birdsgrove House to open at Christmas 714
• Reception guests brave travel chaos 714
• Obituaries 714

Broad Spectrum   715

• Self-regulation and the Society 715

Letters to the Editor   716-719

• Emergency contraception 716
• Physician-assisted suicide
  • Debate among pharmacists needed 716
  • Disastrous 716
• The Journal 716
• Veterinary medicines
  • Urgent attention needed 717
  • Concern at lack of action 717
• NSAIDs 718
• Exemption checking 718
• Locorten-Vioform recall 718
• Travel sickness 718
• Migraine 719
• NHS Plan 719

Continuing Education   720-724

• Nutrition 720-724

Reviews   725

• Books 725
• Exhibition 725

Conference   726-730

• Hot Topic Sessions
  • Expert patients do better 726
  • The use of GM products 726
  • Getting pharmacists on PCTs 726
  • Generics market under review 726
  • Stop smoking guidelines to be reviewed 727
  • Pharmacists and sexual health 727
  • Therapeutic cloning in five years? 727
• History of Pharmacy Session
  • The day pharmacy in Britain entered a new era 728-729
  • The long history of the Order of St John 728-729
• Hospital Pharmacy Session 730

Forum   731-733

• Neonatal and Paediatric Pharmacists Group
  • Organise first, then start research 731
  • Sedation — how is more important than what 731
  • "Unfortunate" omission 731
  • Dublin poster wins travel bursary 731
• British Oncology Pharmacy Association 732-733

International   734-735

• World Congress of Pharmacy 734-735

Products   736

• Prescription products
  • Keppra tablets 736
  • New indication for Caelyx 736
  • Fucidin H 736
  • Betahistine tablets 736
  • Generics products 736
  • Viraferonpeg 736
  • Pneumovax II vaccine 736
  • Micardis tablets 736
  • Discontinued 736
  • Thiopentone injection 736
• Miscellany
  • Pregaine shampoo 736
  • Protectaid vaginal sponge 736
• Price changes 736

Notice-Board   737-738

• Diary 737
• Official Notices 737
• Appointments 737
• Presidents Letter 738
• Future Events 738
• Drug Tariff Ammendments 738
• About People 738
• Announcements 738
• Personal 738

Front Cover Picture

Our front cover picture of mackerel tails
(Sue Baker/Science Photo Library) draws attention to this week’s continuing education article on nutrition. The article looks at the evidence for the use of fish oils in various diseases (p720). Leading article (p705).

Funding withdrawn

Pharmacy out-of-hours services that were to have run in parallel with a walk-in centre in Croydon have had their funding withdrawn by the National Health Service Executive, even though the funding had been approved in principle (p706).

Phenylpropanolamine and stroke

Phenylpropanolamine has been associated with an increased risk of stroke in the United States, but the relevance of the US findings to Britain is being questioned (p709).

The conference

Our coverage of the British Pharmaceutical Conference continues with reports from the hot topic sessions, a history of pharmacy session and a hospital pharmacy session (pp726-730).

Oncology risk management

Participants attending the recent annual symposium of the British Oncology Pharmacy Association discussed the theme of risk management. Report (p732).